Procalcitonin Level and Kinetics in Children With Bacterial Infections

NCT00714402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2011-05-18

No results posted yet for this study

Summary

The purposes of this study are:

1. To determine whether procalcitonin level at admission of pediatric patients with bacterial infections can be used as a marker for prediction of defervescence and hospitalization length
2. To examine the kinetics of procalcitonin in pediatric patients with bacterial infections and persistent fever

Conditions

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • Yechiel Schlesinger, MD · Shaare Zedek Medical Center

Eligibility

Min Age
3 Days
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00714402 on ClinicalTrials.gov